Keyphrases
Cancer Cells
100%
Anticancer Drugs
100%
Achilles Heel
100%
Synergize
66%
Short Hairpin RNA (shRNA)
66%
RNA Synthesis
66%
Tumor Cells
33%
Signaling Pathway
33%
Mechanism of Action
33%
Quantitative Evaluation
33%
Protein Synthesis
33%
FDA-approved Drugs
33%
Related Pathway
33%
Synergistic Drug Combination
33%
Multiple Drugs
33%
RNA Splicing
33%
Affect Responses
33%
Tight Junction
33%
Mammalian Target of Rapamycin (mTOR)
33%
Gene Set Enrichment Analysis
33%
Connectivity Map Analysis
33%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
33%
Loss-of-function Screen
33%
PI3K-AKT-mTOR Pathway
33%
Medicine and Dentistry
Cancer Cell
100%
Anticarcinogen
100%
Drug Combination
100%
Short Hairpin RNA
66%
Mammalian Target of Rapamycin
66%
Proteasome
66%
RNA Synthesis
66%
Protein Kinase B
66%
Tumor Cell
33%
Protein Synthesis
33%
Cell Cycle
33%
Drug
33%
Combination Drug
33%
Tight Junction
33%
Clustered Regularly Interspaced Short Palindromic Repeat
33%
Cell Signaling Pathway
33%
Genome-Wide Analysis of Gene Expression
33%
RNA Splicing
33%
Biochemistry, Genetics and Molecular Biology
Anticancer
100%
Cancer Cell
100%
Proteasome
66%
Protein Kinase B
66%
Small Hairpin RNA
66%
Mammalian Target of Rapamycin
66%
RNA Synthesis
66%
Cell Cycle
33%
Quantitative Technique
33%
RNA Splicing
33%
Protein Biosynthesis
33%
CRISPR
33%
Genome-Wide Analysis of Gene Expression
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Anticarcinogen
100%
Drug Combination
100%
Protein Kinase B
66%
Proteasome
66%
Short Hairpin RNA
66%
Neoplasm
33%
Drug
33%
Combination Drug
33%